Repositioning imatinib for spinal cord injury

作     者：Jacob Kjell Lars Olson 

作者机构：Department of NeuroscienceKarolinska Institutet Department of Physiological GenomicsLudwig-Maximilians-Universität München(LMU) 

出 版 物：《Neural Regeneration Research》 (中国神经再生研究（英文版）)

年 卷 期：2015年第10卷第10期

页      面：1591-1593页

核心收录：

学科分类：0710[理学-生物学] 1002[医学-临床医学] 1001[医学-基础医学(可授医学、理学学位)] 100210[医学-外科学(含：普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 10[医学] 

基　　金：supported by grants from the Swedish Brain Foundation,the Swedish Research Council(K2012-62X-03185-42-4,to LO) Swedish Foundation for Strategic Research,Wings for Life,SSMF,the Swedish Agency for Innovation Systems(VINNOVA),an ERC Advanced Investigator grant(322744,to LO) the Strat Neuro initiative,Karolinska Institutet Research Foundations and the Karolinska Institutet DPA program 

主　　题：Repositioning imatinib for spinal cord injury BSCB BBB 

摘      要：Efforts to pharmacologically restore central nervous system（CNS）function after injury has historically focused on promoting nerve growth with nerve growth factors such as nerve growth factor（NGF）,neurotrophin 3（NT3）and brain-derived neurotrophic factor（BDNF）.